Autophagy differentially regulates tissue tolerance of distinct target organs in graft-versus-host disease models
Journal of Clinical Investigation · 01.03.2024 · 134 (5)
DOI: 10.1172/jci167369 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 01.03.2024. Verfasst von Katherine Oravecz-Wilson und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Rogel Cancer Center, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NCI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Tissue-intrinsic mechanisms that regulate severity of systemic pathogenic immune-mediated diseases, such as acute graft-versus-host disease (GVHD), remain poorly understood. Following allogeneic hematopoietic stem cell transplantation, autophagy, a cellular stress protective response, is induced in host nonhematopoietic cells. To systematically address the role of autophagy in various host nonhematopoietic tissues, both specific classical target organs of acute GVHD (intestines, liver, and skin) and organs conventionally not known to be targets of GVHD (kidneys and heart), we generated mice with organ-specific knockout of autophagy related 5 (ATG5) to specifically and exclusively inhibit autophagy in the specific organs. When compared with wild-type recipients, animals that lacked ATG5 in the gastrointestinal tract or liver showed significantly greater tissue injury and mortality, while autophagy deficiency in the skin, kidneys, or heart did not affect mortality. Treatment with the systemic autophagy inducer sirolimus only partially mitigated GVHD mortality in intestine-specific autophagy-deficient hosts. Deficiency of autophagy increased MHC class I on the target intestinal epithelial cells, resulting in greater susceptibility to damage by alloreactive T cells. Thus, autophagy is a critical cell-intrinsic protective response that promotes tissue tolerance and regulates GVHD severity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Rogel Cancer Center, Ann Arbor, Michigan, USA.
- Dan L. Duncan Comprehensive Cancer Center and.
- Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA.
- Department of Pathology, Yale School of Medicine, Yale University, New Haven, Connecticut, USA.
Förderung
- NHLBI NIH HHS
- NCI NIH HHS
- NIGMS NIH HHS
- Cancer Prevention and Research Institute of Texas
- National Institiute of Health
- National Heart, Lung, and Blood Institute
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Oravecz-Wilson, K., Lauder, E., Taylor, A., Maneix, L., Van Nostrand, J. L., Sun, Y., Li, L., Zhao, D., Liu, C., & Reddy, P. (2024). Autophagy differentially regulates tissue tolerance of distinct target organs in graft-versus-host disease models. Journal of Clinical Investigation, 134(5). https://doi.org/10.1172/jci167369
Vancouver
Oravecz-Wilson K, Lauder E, Taylor A, Maneix L, Van Nostrand JL, Sun Y, et al. Autophagy differentially regulates tissue tolerance of distinct target organs in graft-versus-host disease models. Journal of Clinical Investigation. 2024;134(5). doi:10.1172/jci167369
BibTeX
@article{OraveczWilson2024,
author = {Oravecz-Wilson, Katherine and Lauder, Emma and Taylor, Austin and Maneix, Laure and Van Nostrand, Jeanine L and Sun, Yaping and Li, Lu and Zhao, Dongchang and Liu, Chen and Reddy, Pavan},
title = {Autophagy differentially regulates tissue tolerance of distinct target organs in graft-versus-host disease models},
journal = {Journal of Clinical Investigation},
year = {2024},
volume = {134},
number = {5},
doi = {10.1172/jci167369}
}
EUVIMED